Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

5 Stocks To Buy Now According To This Elite Hedge Fund

Page 1 of 2

Leighton Welch‘s Welch Capital Partners is a long/short hedge fund which uses fundamental valuation to analyze stocks, and which has a focus on healthcare, technology, energy, and industrial companies. According to the firm, Leighton Welch directs a “cash flow driven investment strategy with a top down macro overlay,” and has a public equity portfolio worth $294.15 million as of September 30. Given that Welch Capital Partners just filed its 13F, let’s take a closer look at the fund’s top stock picks of Oracle Corporation (NYSE:ORCL), Envision Healthcare Holdings Inc (NYSE:EVHC), Citigroup Inc (NYSE:C), Zimmer Biomet Holdings Inc (NYSE:ZBH), and Blackstone Group LP (NYSE:BX), to see the stocks that its research and analysis has determined are strong candidates for outperformance.

ATM, bank, machine, money

Most investors don’t understand hedge funds and indicators that are based on hedge funds’ activities. They ignore hedge funds because of their recent poor performance in the bull market. Our research indicates that hedge funds underperformed because they aren’t 100% long. Hedge fund fees are also very large compared to the returns generated and they reduce the net returns experienced by investors. We uncovered that hedge funds’ long positions actually outperformed the market. For instance the 15 most popular small-cap stocks among funds beat the S&P 500 Index by more than 53 percentage points since the end of August 2012. These stocks returned a cumulative of 102% vs. a 48.7% gain for the S&P 500 Index (see the details here). That’s why we believe investors should pay attention to what hedge funds are buying (rather than what their net returns are).

Leighton Welch
Leighton Welch
Welch Capital Partners

#5 Citigroup Inc (NYSE:C)

Shares held (as of September 30): 296,502
Total Value (as of September 30): $14.71 million
Percent of Portfolio (as of September 30): 5.00%

Citigroup Inc (NYSE:C) recently reported third quarter earnings of $1.31 per share on revenues of $18.5 billion, which beat profit estimates by $0.03 per share but missed revenue expectations by $40 million. ‘Bad bank’ Citi Holdings was profitable, with an adjusted quarterly net income of $47 million and adjusted revenues of $1.44 billion. Citigroup also repurchased 36 million shares in the third quarter. Like other banks, Citigroup shares sold off a few months ago because of weak sentiment, but with a price-to-book ratio of 0.78, at some point, the market will realize the strong dollar will not be permanent, and will give Citigroup a higher valuation. Seth Klarman‘s Baupost Group owned 102.55 million Citigroup shares at the end of June.

Follow Citigroup Inc (NYSE:C)
Trade (NYSE:C) Now!

#4 Envision Healthcare Holdings Inc (NYSE:EVHC)

Shares held (as of September 30): 402,020
Total Value (as of September 30): $14.79 million
Percent of Portfolio (as of September 30): 5.03%

Envision Healthcare Holdings Inc (NYSE:EVHC) is Welch Capital Partners’ fourth-largest position, good for 5.03% of its equity portfolio. Shares of the company, which provides outsourced medical services to consumers and hospitals, have retraced substantially in recent months after Community Health Systems (NYSE:CYH) released very lousy preliminary third quarter data due to weak volumes and lower-than-expected sales, caused by a deterioration in revenue payer mix. Investors worry Community Health Systems’ warning is a canary in the coal mine and that margins for the sector will contract in the near-term due to lower demand and a tightening labor market. Analysts are still optimistic, however, as they have a  consensus price target of $40.27 on Envision’s stock, which indicates 43.37% upside.

Follow Envision Healthcare Holdings Inc. (NYSE:EVHC)
Trade (NYSE:EVHC) Now!

The top three stock picks of Welch Capital Partners are disclosed on the second page.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!